Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Elizabeth Thompson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9808-4991; OpenAlex author ID A5081627141; NIH RePORTER profile ID 8375927. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
1
Labs led
0
Collaborators
63
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers, 1 grant · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 5

  1. Safety and immunologic impact of neoadjuvant/adjuvant GVAX, cyclophosphamide, pembrolizumab, and anti-CSF1R agent IMC-CS4 in pancreatic adenocarcinoma. Co-author DOI 10.3389/fimmu.2026.1715761↗
  2. Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002326↗
  3. Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy. Co-author DOI 10.1007/s00268-022-06667-x↗
  4. Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1). Co-author DOI 10.1093/bjs/znac350↗
  5. Evaluation of a Novel Absorbable Radiopaque Hydrogel in Patients Undergoing Image Guided Radiation Therapy for Borderline Resectable and Locally Advanced Pancr… Co-author DOI 10.1016/j.prro.2020.01.013↗

Grants 1

  1. Core 2: Biospecimen/Pathology Core P50CA062924↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard Andrew Burkhart · 4 shared papers, 2020–2026 · strength 0.63
  2. Ralph H. Hruban · 2 shared papers, 1 shared grant, 2022–2024 · strength 0.55
  3. Elizabeth M. Jaffee · 1 shared paper, 1 shared grant, 2022–2026 · strength 0.51
  4. Amol Kumar Narang · 3 shared papers, 2020–2026 · strength 0.46
  5. Jin Peng He · 3 shared papers, 2020–2024 · strength 0.40
  6. Lei Zheng · 2 shared papers, 2022–2026 · strength 0.37
  7. Christopher R. Shubert · 2 shared papers, 2022–2024 · strength 0.30
  8. William R. Burns · 2 shared papers, 2022–2024 · strength 0.30
  9. Kelly J. Lafaro · 2 shared papers, 2022–2024 · strength 0.30
  10. Joseph R. Habib · 2 shared papers, 2022–2024 · strength 0.30
  11. Benedict Kinny‐Köster · 2 shared papers, 2022–2024 · strength 0.30
  12. Bert Vogelstein · 1 shared grant, 2022 · strength 0.27
  13. Francis M Giardiello · 1 shared grant, 2022 · strength 0.27
  14. Robert A. Anders · 1 shared grant, 2022 · strength 0.27
  15. Francis Giardiello · 1 shared grant, 2022 · strength 0.27
  16. Kenneth W. Kinzler · 1 shared grant, 2022 · strength 0.27
  17. Alison P. Klein · 1 shared grant, 2022 · strength 0.27
  18. Michael Goggins · 1 shared grant, 2022 · strength 0.27
  19. Anirban Maitra · 1 shared grant, 2022 · strength 0.27
  20. Scott E Kern · 1 shared grant, 2022 · strength 0.27
  21. Anne Marie Lennon · 1 shared grant, 2022 · strength 0.27
  22. Dung Thi Le · 1 shared paper, 2026 · strength 0.24
  23. Arielle Rose Urman · 1 shared paper, 2026 · strength 0.24
  24. Ana De Jesus‐Acosta · 1 shared paper, 2026 · strength 0.24
  25. Hao Wang · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.